Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of Ischemic-reperfusion Injury by Ex-vivo ATG-perfusion of Kidneys and Livers Prior Organ Transplantation

NCT03377283 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT03377283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03377283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of Ischemic-reperfusion Injury by Ex-vivo ATG-perfusion of Kidneys and Livers Prior Organ Transplantation
Lead sponsor
Medical University Innsbruck
Phase
Phase 4
Overall status
Completed
Start date
August 17, 2012
Completion date
February 24, 2016
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

organ preservation solutions